Macromoltek
Computational antibody design
Austin, United States · Founded 2010 · $24K raised
- Headquarters
- Austin, Texas
- Employees
- 11–50
- Founded
- 2010
- Website
- macromoltek.com
- Total Funding
- $24K
- Last Round
- $24K SeedJul 2015
- Rounds
- 1
About
Macromoltek: Revolutionizing antibody design. Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.
Summary
Macromoltek is an Artificial Intelligence company based in Austin, United States, founded in 2010. It has raised $24K in total across 1 round, most recently a $24K Seed round in Jul 2015.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2015
Similar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...